Deborah Sumari

In the News

Malaria: Call for action to curb insecticide resistance

Ifakara Health Institute (IHI) scientist Gerry Killeen has called for the international community to be bolder in adopting new products for existing interventions such as insecticide treated bed nets, so …

Muhas don is new IHI board member

Prof. Kaaya. Ifakara Health Institute (IHI) Board of Governors (BOG) has appointed Prof. Sylvia Kaaya member of the IHI Board of Trustees (BOT) effective Wednesday January 10, 2018. The appointment …

Recent Projects

Development of a new tool for malaria mosquito surveillance to improve vector control

Malaria transmission is influenced not only by vector abundance, but as well by demographic traits such as vector species and age structure, as these influence the intensity by which the …

Demonstrating complete disruption of residual malaria transmission by eliminating Anopheles funestus mosquitoes from rural Tanzanian villages

In rural south-eastern Tanzania, where malaria prevalence has reduced by >60% since 2000, low-to-moderate transmission still persists despite very high coverage with long-lasting insecticidal bednets. Like in most residual transmission …

Deborah Sumari

Research Scientist and Deputy Head of Interventions and Clinical Trials

Dr. Deborah Sumari is a molecular biologist and Research Scientist in the Interventions and Clinical Trials Department. Dr. Sumari joined the Institute in 2004 as a MSc. Candidate, conducting her research on drug resistant genotypes of Plasmodium falciparum parasites for first line monotherapy malaria treatment (SP) in comparison to new antimalarial drugs (combination therapy-ACT) expected to be deployed countrywide. Her results were amongst those that contributed to the withdrawal of SP as first line treatment of malaria in Tanzania. She attained a Master’s degree in Molecular Biology from the University of Dar es Salaam in 2007. Dr. Sumari obtained her PhD in Life Sciences and Bioengineering from The Nelson Mandela African Institution of Science and Technology in 2016. Her research project was the first study testing and using magnetic cytosmear technique for diagnosing malaria patient in the field. She further plans to apply the magnetic devices in the identification and separation of free labelled-cancer cells. Additionally, Dr Sumari’s has established key collaborations with international institutes, including Cleveland Clinic Foundation and CASE Western Reserve University, and CDC Atlanta – Division of Parasitic Diseases and Malaria on malaria surveillance studies. Her other interests include evaluation of non-communicable diseases in children, establishment of a point-of-care device that can frequently assess the effect of intervention and control measures in the country. Dr Sumari has significant experience in her field and strong collaborative skills that strengthen research activities in the Institute.

View Debora’s Research Interests and Publications

Projects

No items found
A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016